Fusobacterium nucleatum-mimicking nanovehicles to overcome chemoresistance for breast cancer treatment by eliminating tumor-colonizing bacteria
Author:
Chen Linfu,
Shen Jingjing,
Kang Zheyu,
Zhang Zemin,
Zheng Zixuan,
Zhang Lin,
Xiao Zhisheng,
Zhang Qiang,
Fang Huapan,
Zhou Jun,
Wang Yudong,
Yang Yang,
Liu Zhuang,
Chen QianORCID
Reference42 articles.
1. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial;Kuerer;Lancet Oncol.,2022
2. Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer: final 10-year analysis of the open-label, single-arm, phase 2 APT trial;Tolaney;Lancet Oncol.,2023
3. Key steps for effective breast cancer prevention;Britt;Nat. Rev. Cancer,2020
4. Breast cancer statistics, 2022;Giaquinto;CA Cancer J. Clin.,2022
5. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database;Autier;BMJ,2011
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献